Sarala Sarah
机构：Taconic (United States)
发表论文 2 篇 · 总被引 56 次 · h-index 2
代表论文
- Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases (2020 · European Journal of Pharmacology · 被引 47)
- Ruxolitinib, a JAK1/JAK2 Selective Inhibitor, Ameliorates Acute and Chronic Steroid-Refractory Gvhd Mouse Models (2021 · Immunotherapy · 被引 9)